Sukyung
Sukyung Lee, Seoul KR
Patent application number | Description | Published |
---|---|---|
20090054259 | METHODS FOR INDUCING COMPLETE APOPTOSIS OF LIVER CELLS EXPRESSING HBCHI PROTEIN AND SCREENING FOR SUBSTANCES OR GENES THAT INHIBIT THE APOPTOSIS - A complete apoptosis of liver cells expressing HBx protein is achieved with a NF-κB inhibitor treatment. This method is useful in screening for substances or genes that inhibit complete apoptosis of liver cells expressing HBx protein, and, further, the substance or gene may be employed as an active ingredient of a therapeutic composition for treating hepatitis or hepatocarcinoma induced by HBV infection. | 02-26-2009 |
20110243917 | COMPOSITION FOR THE PREVENTION AND TREATMENT OF ABSENCE SEIZURES COMPRISING PKC AGONIST AS AN EFFECTIVE INGREDIENT - The present invention relates to a composition comprising PKC agonist as an active ingredient. More precisely, the present inventors confirmed that absence seizure specific SWD was reduced by administrating PKC agonist into an animal model. Therefore, the composition of the present invention comprising PKC agonist as an active ingredient can be effectively used for the prevention and treatment of absence seizure and for the production of health improving functional food. | 10-06-2011 |
20120143074 | METHOD OF EVALUATING SUITABILITY FOR DRUG THERAPY FOR THE PREVENTION AND TREATMENT OF ANXIETY DISORDERS USING CHOLINERGIC TYPE II THETA RHYTHM - The present invention relates to a drug suitability assessment method for the prevention or treatment of anxiety disorders using the cholinergic type II theta rhythm, and, more specifically, to a method for detecting individuals suffering from anxiety disorders induced by an abnormality occurring in the cholinergic system using the type II theta rhythm profile which is based on findings that the cholinergic type II theta rhythm is lower in an animal anxiety model than in normal subjects and that cholinergic drug treatment induces the cholinergic type II theta rhythm to return to normal and reduces anxiety and thereby making it possible to determine if a subject can be appropriately administered with a cholinergic drug and to monitor progress after cholinergic drug treatment. | 06-07-2012 |
Sukyung Lee, Yongin-Si KR
Patent application number | Description | Published |
---|---|---|
20160079593 | COMPOSITE ANODE ACTIVE MATERIAL, ANODE AND LITHIUM BATTERY CONTAINING THE MATERIAL, AND METHOD OF PREPARING THE COMPOSITE ANODE ACTIVE MATERIAL - Provided is a composite anode active material with pores having a composition represented by Formula 1, and, the composite anode active material contains an amorphous phase including Si and a nano-crystalline phase including a metal silicide: | 03-17-2016 |
Sukyung Lee, Daejeon KR
Patent application number | Description | Published |
---|---|---|
20160089637 | INORGANIC-ORGANIC HYBRID NANOPOROUS MATERIAL WITH NITROGEN SELECTIVE ADSORPTIVITY AND METHOD FOR SEPARATING NITROGEN-CONTANING GAS MIXTURE USING THE SAME - The present invention relates to a nitrogen adsorbent having nitrogen selective adsorptivity by including an organic-inorganic hybrid nanoporous material having a coordinatively unsaturated metal site with density of 0.2 mmol/g to 10 mmol/g in a skeleton, surface or pore; and use thereof, such as a device separating nitrogen from a gas mixture containing nitrogen and methane, a pressure swing adsorption separation device and a temperature swing adsorption separation device for separating nitrogen provided, a method for separating nitrogen and methane from a gas mixture containing nitrogen and methane, a device for separating nitrogen, oxygen or argon, a method for separating nitrogen, oxygen or argon from a gas mixture containing nitrogen, oxygen or argon, and a method for preparing nitrogen or high purity inert gas all separated from a gas mixture containing nitrogen and inert gas. | 03-31-2016 |